Home
Market Capitalization of Dr Reddys Laboratories Ltd

Dr Reddys Laboratories Ltd
NSE: DRREDDY
Market Cap
Key Highlights
- The Market Cap of Dr Reddys Laboratories Ltd is ₹ 96123 crore as of 21 Feb 25 .
- The Latest Trading Price of Dr Reddys Laboratories Ltd is ₹ 1151 as of 21 Feb 15:30 .
- The Dividend Payouts of Dr Reddys Laboratories Ltd changed from ₹ 20 on Jul 15, 2019 to ₹ 40 on Jul 16, 2024 . This represents a CAGR of 12.25% over 6 years.

Dr Reddys Laboratories Ltd
NSE: DRREDDY
Share Price
Market Price of Dr Reddys Laboratories Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 1151.95 |
20 Feb 2025 | 1170.9 |
19 Feb 2025 | 1164.7 |
18 Feb 2025 | 1197.85 |
17 Feb 2025 | 1199.75 |
14 Feb 2025 | 1195.85 |
13 Feb 2025 | 1223.3 |
12 Feb 2025 | 1215.9 |
11 Feb 2025 | 1211.8 |
10 Feb 2025 | 1220.85 |
SWOT Analysis Of Dr Reddys Laboratories Ltd
BlinkX Score for Dr Reddys Laboratories Ltd
Asset Value vs Market Value of Dr Reddys Laboratories Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Dr Reddys Laboratories Ltd
Historical P/E Ratio of Dr Reddys Laboratories Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Dr Reddys Laboratories Ltd
Historical Revenue of Dr Reddys Laboratories Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Dr Reddys Laboratories Ltd
Historical EBITDA of Dr Reddys Laboratories Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Dr Reddys Laboratories Ltd
Historical Net Profit of Dr Reddys Laboratories Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Dr Reddys Laboratories Ltd
Historical Dividend Payouts of Dr Reddys Laboratories Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payouts of Dr Reddys Laboratories Ltd
About Dr Reddys Laboratories Ltd
- Dr Reddy's Laboratories Ltd (DRL) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives.
- Through its three businesses - Pharmaceutical Services &Active Ingredients, Global Generics and Proprietary Products - Dr. Reddy's offers a portfolio of products and services including Active Pharmaceutical Ingredients (APIs), custom pharmaceutical services, generics, biosimilars and differentiated formulations.
- The company's major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology.
- Dr. Reddy's operates in markets across the globe.
- Its major markets include - USA, India, Russia & CIS countries, and Europe. Dr Reddy's Laboratories was incorporated in the year 1984 in Hyderabad.
Dr Reddys Laboratories Ltd News Hub
Dr Reddys Laboratories Ltd gains for third straight session
Dr Reddys Laboratories Ltd gained for a third straight session today. The stock is quoting at Rs 707
Read more
21 Aug 24
Dr Reddy's formulations manufacturing units receives EIR from USFDA
Dr Reddys Laboratories has received the Establishment Inspection Report (EIR) for its formulations m
Read more
12 Aug 24
Dr Reddys allots 29,790 equity shares under ESOP
Dr Reddys Laboratories has allotted 29,790 equity shares of Rs.5/- each underlying 29,790 ADRs pursu
Read more
07 Aug 24
Dr Reddy's Labs Andhra Pradesh facility gets EIR from USFDA
The inspection has been classified as voluntary action indicated (VAI) and has been closed according
Read more
06 Sept 24